An improved process for the preparation of trimethylhydrazine and its coupling with an activated acid intermediate

Organic Process Research and Development

Volumn 8, Issue 3, 2004, Pages 360-362

  García Rubio, Silvina ^a   Wilson, Chandra D ^a   Renner, Deborah A ^a   Rosser, John O ^a   Patra, Debasis ^a   Gregory Reid, J ^a   Pines, Seemon H ^a  

^a ALBANY MOLECULAR RESEARCH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACID; HYDRAZINE DERIVATIVE; TRIMETHYLHYDRAZINE; UNCLASSIFIED DRUG;

ARTICLE; ENANTIOMER; SCALE UP; SYNTHESIS;

EID: 3042690482     PISSN: 10836160     EISSN: None     Source Type: Journal    
DOI: 10.1021/op0342022     Document Type: Article

References (25)

1. (a) Andersen, P.; Ankersen, M.; Jessen, C. U.; Lehman, S. V. Org. Proc. Res. Dev. 2002, 6, 367.
2. (b) Hanefeld, W.; Von Goesseln, H. J. Arch. Pharm. (Weinheim, Ger.) 1991, 324, 917.
3. (c) Riebli, P. EP 430033 A2 19910605, 1991.
4. (d) Chong, J. M.; Mar, E. Tetrahedron Lett. 1990, 13, 1981.
5. (e) Walter, W.; Krische, B.; Voss, J. J. Chem. Res., Synop. 1978, 332.
6. (f) Lowrie, H. S. U.S. Patent 19650506, 1967.
7. (g) Levitt, G. U.S. Patent 19670509, 1967.
8. (h) Lowrie, H. S. J. Med. Chem. 1966, 9, 664.
9. Sensi, P.; Maggi, N.; Ballota, R.; Fürèsz, S.; Pallanza, R.; Arioli, V. J. Med. Chem. 1964, 7, 596.
10. (a) Class, J. B.; Aston, J. G. J. Am. Chem. Soc. 1951, 73, 2359.
11. (b) Class, J. B.; Aston, J. G.; Oakwood, T. S. J. Am. Chem. Soc. 1953, 75, 2937.
12. (a) Horvitz, D. U.S. Patent 3,182,087, 1965.
13. (b) Sidi, H.; Paramus, N. J. U.S. Patent 3,517,064, 1970.
14. (a) Klages, F.; Nober, G.; Kircher, K.; Bock, M. Justus Liebigs Ann. Chem. 1941, 547, 12, 32.
15. (b) Hinman, R. L. J. Am. Chem. Soc. 1956, 78, 1645.
16. (c) Beltrami, R. T.; Bisell, E. R. J. Am. Chem. Soc. 1956, 78, 2467.
17. (d) Andersen, P.; Ankersen, M.; Jessen, C. U.; Lehman, S. V. Org. Process Res. Dev. 2002, 6, 367.
18. For a discussion of the complexation on aluminum ions with polydentate ligands such as ethylene glycol, see: McMahon, C. N.; Alemany, L.; Callender, R. L.; Bott, S. G.; Barron, A. R. Chem. Mater. 1999, 11, 3181.
19. Saraswathi, M.; Miller, J. M. Can. J. Chem. 1996, 74, 2221.
20. 1H NMR spectra.
21. For information on the toxicity of TMH, see: Toth, B. Cancer 1977, 40, 2427.
22. Nagel, D.; Toth, B.; Kupper, R.; Erickson, J. J. Natl. Cancer Inst. 1976, 57, 187.
23. The difference of boiling temperatures between TMH (bp 59-61°C) and 1,4-dioxane (bp 100°C) would allow obtaining higher concentrations of TMH provided a fractionating column was used.
24. The choices of coupling agents were made on the basis of the reported effectiveness of phosphinic reagents in the coupling of hindered amino acids and on the fact that PyBrop had been employed in this coupling with moderate success. See: Humphrey, J. M.; Chamberlin, A. R. Chem. Rev. 1997, 97, 2243.
25. 2).